BPC157 Therapy Des Moines Peptide Therapy Iowa IV BPC 157: Experimental Peptide Creates Risk for Athletes The peptide problem: Hype is outrunning the evidence BPC 157 has already hit the mainstream, but should it hit your bloodstream? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York